256 related articles for article (PubMed ID: 7888825)
1. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control.
Can Fam Physician; 1994 Dec; 40():2121-3. PubMed ID: 7888825
[No Abstract] [Full Text] [Related]
2. Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.
Squires SG; Pelletier L; Mungai M; Tsang R; Collins F; Stoltz J
Can Commun Dis Rep; 2000 Nov; 26(21):177-82. PubMed ID: 11107657
[No Abstract] [Full Text] [Related]
3. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
[No Abstract] [Full Text] [Related]
4. Epidemiology and meningococcal serogroup distribution in the United States.
Hershey JH; Hitchcock W
Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
[No Abstract] [Full Text] [Related]
5. [Continuing increase in the incidence of serogroup C meningococcal disease. Should we decide to vaccinate?].
Soult Rubio JA; Muñoz Sáez M; López Castilla JD; Rodríguez Becerra A; Romero Parreño A; Tovaruela Santos A
An Esp Pediatr; 2000 Jul; 53(1):75-6. PubMed ID: 11203416
[No Abstract] [Full Text] [Related]
6. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
[No Abstract] [Full Text] [Related]
7. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
[No Abstract] [Full Text] [Related]
8. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
Krízová P; Musílek M; Kalmusová J
Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
[TBL] [Abstract][Full Text] [Related]
9. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
[No Abstract] [Full Text] [Related]
10. Serogroup B meningococcal disease--Oregon, 1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Feb; 44(7):121-4. PubMed ID: 7845348
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal infections in Quebec--1991-92.
Lavigne P; Boulianne N; Fortin C; Naccache H; Douville-Fradet M
Can Commun Dis Rep; 1992 Aug; 18(15):113-6. PubMed ID: 1290994
[No Abstract] [Full Text] [Related]
12. Neisseria meningitidis carriage during an outbreak of serogroup C disease.
Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC
Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
Arreaza L; de la Fuente L; Fernández S; Vázquez JA
Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
[TBL] [Abstract][Full Text] [Related]
14. Meningococci.
Sippel JE
Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
[No Abstract] [Full Text] [Related]
15. Serogroup B meningococcal disease: new outbreaks, new strategies.
Wenger JD
JAMA; 1999 Apr; 281(16):1541-3. PubMed ID: 10227326
[No Abstract] [Full Text] [Related]
16. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R
Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849
[TBL] [Abstract][Full Text] [Related]
17. ABC of meningococcal diversity.
Feavers IM
Nature; 2000 Mar; 404(6777):451-2. PubMed ID: 10761900
[No Abstract] [Full Text] [Related]
18. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
[TBL] [Abstract][Full Text] [Related]
19. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain).
Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA;
Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816
[TBL] [Abstract][Full Text] [Related]
20. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
